Skip to content

Effect of Geng-nian-zi-shen oral solution on the improvement of hypoestrogenemia caused by GnRH-a after endometriosis surgery

Effect of Geng-nian-zi-shen oral solution on the improvement of hypoestrogenemia caused by GnRH-a after endometriosis surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069429
Enrollment
Unknown
Registered
2023-03-16
Start date
2023-03-16
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

GNZS Group:Geng-nian-zi-shen oral solution

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-45 years who underwent laparoscopic endometriosis cyst removal in our hospital and planned to receive GnRH-a treatment for >= 3 cycles; 2. Meets the syndrome standard of "kidney deficiency and blood stasis"; 3. Voluntary treatment and has signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients suffering from serious cardiovascular and cerebrovascular diseases, diabetes, hypertension, liver and kidney insufficiency and other basic diseases with poor control; 2. Suspected or confirmed breast cancer, or other hormone-dependent tumor; 3. Untreated endometrial hyperplasia; 4. History or present venous thrombosis (deep vein thrombosis, pulmonary embolism, etc.); 5. Diagnosed porphyria disease; 6. Severe allergic constitution or allergic history to related drugs; 7. Participants who are currently participating in or have participated in other clinical trials within 1 month.

Design outcomes

Primary

MeasureTime frame
Kupperman scale;TCM syndrome score;

Secondary

MeasureTime frame
visual analogue scale;estradiol;follicle-stimulating hormone;luteinizing hormone;BMD (bone mineral density);osteocalcin;EHP-30 scale, Endometriosis Health Profile Questionnaire;female sexual function index, FSFI;anti miillerian hormone;gynecological color ultrasound;gynecologic examination;

Countries

China

Contacts

Public ContactXiangdan Hu

Guangdong Provincial Hospital of Chinese Medicine

doctor@163.com+86 15920119600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026